[go: up one dir, main page]

WO2010004584A3 - Procédé de production d'un composé antidiabétique à partir d'une culture de racine de catharanthus roseus - Google Patents

Procédé de production d'un composé antidiabétique à partir d'une culture de racine de catharanthus roseus Download PDF

Info

Publication number
WO2010004584A3
WO2010004584A3 PCT/IN2009/000389 IN2009000389W WO2010004584A3 WO 2010004584 A3 WO2010004584 A3 WO 2010004584A3 IN 2009000389 W IN2009000389 W IN 2009000389W WO 2010004584 A3 WO2010004584 A3 WO 2010004584A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
catharanthus roseus
root culture
present
diabetic compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2009/000389
Other languages
English (en)
Other versions
WO2010004584A2 (fr
Inventor
Asis Datta
Samir Bhattacharya
C. Bikas Pal
Jayanti Sen
Suman Dasgupta
Anindita Biswas
Jyoti Batra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2010004584A2 publication Critical patent/WO2010004584A2/fr
Publication of WO2010004584A3 publication Critical patent/WO2010004584A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne le traitement du diabète au moyen de serpentine. L'invention concerne plus particulièrement un procédé de production de serpentine dans une culture de racines chevelues de Catharanthus roseus, et l'effet d'un extrait de racine chevelue sur la réduction de glucose sanguin chez un sujet. L'invention concerne enfin l'identification et l'isolation à partir de l'extrait d'un composé biologiquement actif.
PCT/IN2009/000389 2008-07-09 2009-07-09 Procédé de production d'un composé antidiabétique à partir d'une culture de racine de catharanthus roseus Ceased WO2010004584A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1649/DEL/2008 2008-07-09
IN1649DE2008 2008-07-09

Publications (2)

Publication Number Publication Date
WO2010004584A2 WO2010004584A2 (fr) 2010-01-14
WO2010004584A3 true WO2010004584A3 (fr) 2010-08-19

Family

ID=41507518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000389 Ceased WO2010004584A2 (fr) 2008-07-09 2009-07-09 Procédé de production d'un composé antidiabétique à partir d'une culture de racine de catharanthus roseus

Country Status (1)

Country Link
WO (1) WO2010004584A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102613088A (zh) * 2012-04-23 2012-08-01 上海安体康生植物化学有限公司 培育耐盐耐低温长春花株系快速繁殖的方法
WO2015095625A1 (fr) * 2013-12-19 2015-06-25 Rhizoflora, Inc. Composition d'activateur de plantes
CN111500625A (zh) * 2020-05-18 2020-08-07 扬州大学 一种利用发根农杆菌诱导产生玫瑰毛状根的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639876A1 (de) * 1976-09-04 1978-03-09 Boehringer Mannheim Gmbh Verfahren zur herstellung der alkaloide raubasin und serpentin durch in vitro-zuechtung von zellen von catharanthus
US4578531A (en) * 1982-06-09 1986-03-25 At&T Bell Laboratories Encryption system key distribution method and apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639876A1 (de) * 1976-09-04 1978-03-09 Boehringer Mannheim Gmbh Verfahren zur herstellung der alkaloide raubasin und serpentin durch in vitro-zuechtung von zellen von catharanthus
US4578531A (en) * 1982-06-09 1986-03-25 At&T Bell Laboratories Encryption system key distribution method and apparatus

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BHADRA R ET AL: "Production of indole alkaloids by selected hairy root lines of Catharanthus roseus.", BIOTECHNOLOGY AND BIOENGINEERING 5 MAR 1993, vol. 41, no. 5, 5 March 1993 (1993-03-05), pages 581 - 592, XP002565273, ISSN: 0006-3592 *
BHADRA R ET AL: "Transient studies of nutrient uptake, growth, and indole alkaloid accumulation in heterotrophic cultures of hairy roots of Catharanthus roseus.", BIOTECHNOLOGY AND BIOENGINEERING 5 AUG 1997, vol. 55, no. 3, 5 August 1997 (1997-08-05), pages 527 - 534, XP002565274, ISSN: 0006-3592 *
PARKER JANICE C: "Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus", ADVANCED DRUG DELIVERY REVIEWS 5 NOV 2002,, vol. 54, no. 9, 5 November 2002 (2002-11-05), pages 1173 - 1197, XP002562968 *
PEEBLES CHRISTIE A M ET AL: "Effects of terpenoid precursor feeding on Catharanthus roseus hairy roots over-expressing the alpha or the alpha and beta subunits of anthranilate synthase", BIOTECHNOLOGY AND BIOENGINEERING, vol. 93, no. 3, February 2006 (2006-02-01), pages 534 - 540, XP002565276, ISSN: 0006-3592 *
SCRAGG A H ET AL: "Effect of scale-up on serpentine formation by Catharanthus roseus suspension cultures", ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 9, no. 10, 1 October 1987 (1987-10-01), pages 619 - 624, XP023679097, ISSN: 0141-0229, [retrieved on 19871001] *
TOIVONEN L ET AL: "Studies on the optimization of growth and indole alkaloid production by hairy root cultures of Catharanthus roseus.", BIOTECHNOLOGY AND BIOENGINEERING 25 MAR 1991, vol. 37, no. 7, 25 March 1991 (1991-03-25), pages 673 - 680, XP002565275, ISSN: 0006-3592 *

Also Published As

Publication number Publication date
WO2010004584A2 (fr) 2010-01-14

Similar Documents

Publication Publication Date Title
WO2011011300A8 (fr) Différentiation de cellules souches embryonnaires humaines
WO2010057039A3 (fr) Encapsulation de cellules pancréatiques dérivées de cellules souches pluripotentes humaines
WO2012021698A3 (fr) Traitement du diabète au moyen de cellules précurseurs endocrines pancréatiques
SI1935331T1 (sl) Postopek za pripravo modificiranih elektrod, elektrode pripravljene z omenjenim postopkom in encimatski biosenzorji, ki obsegajo omenjene elektrode
BRPI0916560A2 (pt) análogo de insulina, ácido nucléico, vetor de expressão, célula hospedeira e método de tratamento de um paciente.
WO2008051568A3 (fr) Procédés et compositions pour le traitement de déficits osseux au moyen de populations de cellules placentaires
WO2010083170A3 (fr) Stimulation cellulaire à l'aide de nanocristaux de semi-conducteurs
WO2012149468A3 (fr) Instruments et procédés d'implantation de substrats ensemencés de cellules
WO2012166844A3 (fr) Traitement de la douleur à l'aide de cellules souches placentaires
WO2009151907A3 (fr) Compositions et procédés permettant d'utiliser des cellules pour traiter le tissu cardiaque
ZA201007059B (en) Quinoxalinone derivatives as insulin secretion stimulators,methods for obtaining them and use thereof for the treatment of diabetes
WO2009103067A3 (fr) Compositions et procédés de traitement de l’asthme
WO2007127408A3 (fr) Méthodes pour traiter le diabète
WO2008153366A3 (fr) Procede de fabrication de facteur ix de la coagulation sanguine recombinant actif
WO2011075606A3 (fr) Variants de polypeptide hyperglycosylé et procédés d'utilisation
MX2011008196A (es) Metodo para la produccion de fideo y preparacion de enzima para modificar el fideo.
IL207719A (en) Pyrenzinone Derivatives as Insulators, Methods for Preparing and Using them to Treat Diabetes
WO2012016229A3 (fr) Traitement à l'ocytocine visant à améliorer la mémoire et abaisser le taux de glucose dans le sang
WO2011003062A3 (fr) Compositions probiotiques et procédés s'y rapportant
WO2010004584A3 (fr) Procédé de production d'un composé antidiabétique à partir d'une culture de racine de catharanthus roseus
IL207722A0 (en) Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
WO2013025073A3 (fr) Composition pour la prévention ou le traitement de complications du diabète contenant un extrait de quamoclit pennata
MX346039B (es) Solucion farmaceutica bebible de telmisartan.
WO2007135563A3 (fr) Utilisation de glis3 pour la préparation de cellules bêta pancréatiques fonctionnelles
WO2012145646A8 (fr) Méthodes de traitement de la maladie de tay-sachs, de la maladie de sandhoff, et des gangliosidoses à gm1

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09787599

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09787599

Country of ref document: EP

Kind code of ref document: A2